http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2540464-C2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4e4823b20c2091b191f85b00f6ac2220
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-625
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28
filingDate 2012-05-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2015-02-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8a524cb03e8598487e3e6ddf1163fd2b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bce57662845d3fa228f3c0e27c6ef1a0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8b26bc2545c684a1329d3cb15fb598b0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6069252339e2b107125f900b2c596f3a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c5db1eae86862e22f6895add957a7d46
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4eb8cab63759ecf76c973869bd9b8992
publicationDate 2015-02-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RU-2540464-C2
titleOfInvention Water-soluble salamide derivative possessing tranquilising, nootropic and analgesic activity
abstract FIELD: medicine, pharmaceutics. n SUBSTANCE: invention can be used in chemical-pharmaceutical industry for preparing effective tranquilising salamide preparations and analgesics. What is presented is using salicyloyl morpholine sodium salt of formula (I) as a tranquilising, nootropic and analgesic agent possessing low gastric toxicity. n EFFECT: implementing the declared application with the therapeutic index of salicyloyl morpholine of formula (I) is 3 times higher than that of mexidole, and 9,5 times higher than that of aspirin. n 5 tbl
priorityDate 2012-05-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2135485-C1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-5564561-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6291458-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-1265924-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-3287364-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2495032-C1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54693468
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448835290
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449686023
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5147
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8083
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451965594
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID114681
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16760658
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID122298
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID229478
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419497675
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54683951
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415752263
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419556224
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID447475885
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID74041
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2244
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID67712922
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451085262
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415888329
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419474861
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559059

Total number of triples: 47.